# ExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's Disease

> **NCT02263885** · NA · COMPLETED · sponsor: **InSightec** · enrollment: 20 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DEVICE:** ExAblate Transcranial System

## Key facts

- **NCT ID:** NCT02263885
- **Lead sponsor:** InSightec
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2019-05-15
- **Final completion:** 2019-07-26
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02263885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02263885, "ExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02263885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*